These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

729 related items for PubMed ID: 29943313

  • 1. 18F-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value.
    Liu S, Feng Z, Wen H, Jiang Z, Pan H, Deng Y, Zhang L, Ju X, Chen X, Wu X.
    Jpn J Radiol; 2018 Sep; 36(9):544-550. PubMed ID: 29943313
    [Abstract] [Full Text] [Related]

  • 2. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY, Jeong SY, Chong GO, Son SH, Jung JH, Kim DH, Lee SW, Ahn BC, Lee J.
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT as predictor of tumour biology and prognosis in epithelial ovarian carcinoma.
    González García B, García Vicente AM, Jiménez Londoño GA, Pena Pardo FJ, Bellón Guardia ME, Talavera Rubio MP, Palomar Muñoz A, Gómez Herrero P, Soriano Castrejón ÁM.
    Rev Esp Med Nucl Imagen Mol; 2017 Mar; 36(4):233-240. PubMed ID: 28284928
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in patients with epithelial ovarian cancer.
    Lee M, Lee H, Cheon GJ, Kim HS, Chung HH, Kim JW, Park NH, Song YS.
    Eur Radiol; 2017 Jan; 27(1):16-23. PubMed ID: 27121932
    [Abstract] [Full Text] [Related]

  • 5. Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer.
    Mayoral M, Paredes P, Saco A, Fusté P, Perlaza P, Tapias A, Fernandez-Martinez A, Vidal L, Ordi J, Pavia J, Martinez-Roman S, Lomeña F.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018 Jan; 37(2):80-86. PubMed ID: 28869177
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J.
    Gynecol Oncol; 2016 Jan; 140(1):29-35. PubMed ID: 26515076
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
    Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, Ditto A, Lecce F, Mira M, Donfrancesco C, Raspagliesi F, Crippa F.
    Tumori; 2016 Jan; 102(1):103-7. PubMed ID: 26350201
    [Abstract] [Full Text] [Related]

  • 8. Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.
    Vargas HA, Burger IA, Goldman DA, Miccò M, Sosa RE, Weber W, Chi DS, Hricak H, Sala E.
    Eur Radiol; 2015 Nov; 25(11):3348-53. PubMed ID: 25916387
    [Abstract] [Full Text] [Related]

  • 9. F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.
    Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G.
    Eur J Radiol; 2017 Aug; 93():107-113. PubMed ID: 28668403
    [Abstract] [Full Text] [Related]

  • 10. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
    Fruscio R, Sina F, Dolci C, Signorelli M, Crivellaro C, Dell'Anna T, Cuzzocrea M, Guerra L, Milani R, Messa C.
    Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
    [Abstract] [Full Text] [Related]

  • 11. Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers.
    Wang J, Liu L, Pang H, Liu L, Jing X, Li Y.
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1315-1327. PubMed ID: 35979992
    [Abstract] [Full Text] [Related]

  • 12. Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.
    Liu S, Feng Z, Jiang Z, Wen H, Xu J, Pan H, Deng Y, Zhang L, Ju X, Chen X, Wu X.
    Nucl Med Commun; 2018 Oct; 39(10):928-935. PubMed ID: 29771717
    [Abstract] [Full Text] [Related]

  • 13. The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
    Amit A, Hodes A, Lavie O, Keidar Z, Matanes E, Lowenstein L.
    Surg Oncol; 2017 Dec; 26(4):347-351. PubMed ID: 29113651
    [Abstract] [Full Text] [Related]

  • 14. Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer.
    Chung HH, Lee M, Kim HS, Kim JW, Park NH, Song YS, Cheon GJ.
    Eur Radiol; 2017 Nov; 27(11):4510-4515. PubMed ID: 28593431
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.
    Mayoral M, Fernandez-Martinez A, Vidal L, Fuster D, Aya F, Pavia J, Pons F, Lomeña F, Paredes P.
    Rev Esp Med Nucl Imagen Mol; 2016 Nov; 35(2):88-95. PubMed ID: 26541072
    [Abstract] [Full Text] [Related]

  • 16. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V, Cascales-Campos PA, Gil J, Frutos L, Andrade RJ, Fuster-Quiñonero M, Feliciangeli E, Gil E, Parrilla P.
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [Abstract] [Full Text] [Related]

  • 17. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.
    Chung HH, Kim JW, Park NH, Song YS, Cheon GJ.
    Eur Radiol; 2018 May; 28(5):2107-2114. PubMed ID: 29260365
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
    Matsuura T, Otsuka I, Ouchi T, Ouchi E, Asano R, Miyasaka N.
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ, Kim YM, Jung PS, Lee JJ, Kim JK, Kim YT, Nam JH.
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.